# Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/long-term-study-of-patients-with-type-2-diabetes-and-moderate-renal-impairment/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Donald E. Kohan,Paola Fioretto,Weihua Tang,James F. List |
| Citations | 647 |
| DOI | 10.1038/ki.2013.356 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1038/ki.2013.356 |
| OpenAlex ID | https://openalex.org/W2030192134 |
| PMID | 24067431 |
| Type | article |
| Year | 2013 |

## Paper authors

- [Paola Fioretto](https://scholariq.org/researchers/paola-fioretto/)

## Paper journal

- [Kidney International](https://scholariq.org/journals/kidney-international/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.